Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

448.75
+0.49500.11%
Volume:102.22K
Turnover:45.91M
Market Cap:22.24B
PE:42.66
High:457.43
Open:455.40
Low:446.27
Close:448.25
52wk High:625.99
52wk Low:228.00
Shares:49.56M
Float Shares:48.15M
Volume Ratio:0.59
T/O Rate:0.21%
Dividend:0.80
Dividend Rate:0.18%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:9.98
PE(LYR):42.66

Loading ...

Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Cemacabtagene Ansegedleucel (Cema-Cel) as First-Line Consolidation Therapy for Large B-Cell Lymphoma

GlobeNewswire
·
Jul 29

Carpenter Technology Reinstates Former CEO After Sudden Loss

TIPRANKS
·
Jul 29

Movement Alert|Carpenter Technology Falls 5.11% in Regular Trading, CEO Brian Malloy Passes Away Suddenly

Market Focus
·
Jul 27

Carpenter Names Tony Thene CEO After Brian Malloy’s Death

Reuters
·
Jul 27

Carpenter Technology Corp - President and CEO Brian Malloy Passes Away

THOMSON REUTERS
·
Jul 27

Carpenter Technology Corp - Appoints Tony Thene as Chief Executive Officer Effective Immediately

THOMSON REUTERS
·
Jul 27

Press Release: Carpenter Technology Announces the Passing of Brian Malloy

Dow Jones
·
Jul 27

Earning Preview: Carpenter Technology revenue expected to increase by 8.93%, institutions lean bullish on margin expansion

Earnings Agent
·
Jul 24

Prominent Platform Company Ordered to Pay 547.9 Million Yuan in Back Taxes for Cross-Border Tax Evasion

Deep News
·
Jul 22

Billionaires are Loading up on These Superior Stocks. Why it Pays to Follow Their Money.

Dow Jones
·
Jul 18

JPMorgan ups Carpenter target, places on ‘Negative Catalyst Watch’

TIPRANKS
·
Jul 14

U.S. Research Roundup: Airbnb, Doordash, Zillow Group

Reuters
·
Jul 14

Billionaires are Loading up on These Superior Stocks. Why it Pays to Follow Their Money.

Dow Jones
·
Jul 14

J.P. Morgan Remains a Buy on Carpenter Technology (CRS)

TIPRANKS
·
Jul 13

Poolbeg Pharma Begins POLB 001 Trial, Targets Major CRS Market Opportunity

TIPRANKS
·
Jul 13

Is Carpenter Technology (CRS) Fully Valued Following Its Russell Index Removals?

Simply Wall St.
·
Jul 10

Carpenter Tech is Maintained at Positive by Susquehanna

Dow Jones
·
Jul 10

Genmab Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

GlobeNewswire
·
Jul 07

Carpenter Technology Announces Conference Call and Webcast

GlobeNewswire
·
Jul 01

Carpenter Tech is Maintained at Overweight by Keybanc

Dow Jones
·
Jun 30